Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study To Evaluate The Safety, Tolerability and Pharmacokinetics Of BH009 In Patients With Advanced Head And Neck Squamous (Non-nasopharyngeal) And Ovarian Cancer

NCT06232863 is registered in ClinicalTrials.gov with Zhuhai Beihai Biotech Co., Ltd as lead sponsor.

NCT NCT06232863
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06232863 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study To Evaluate The Safety, Tolerability and Pharmacokinetics Of BH009 In Patients With Advanced Head And Neck Squamous (Non-nasopharyngeal) And Ovarian Cancer
Lead sponsor
Zhuhai Beihai Biotech Co., Ltd
Phase
Phase 1
Overall status
Unknown status
Start date
January 18, 2023
Completion date
April 30, 2024
Enrollment
24 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumor, adult